Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomas
Cancer Immunology Immunotherapy1990Vol. 32(2), pp. 105–109
Citations Over TimeTop 17% of 1990 papers
Related Papers
- → chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts(2007)28 cited
- → The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin(1987)34 cited
- → Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice(1992)7 cited
- A phase I study: Immunotoxin targeting the epithelial glycoprotein 2 (ESA/Ep-CAM) in cancer patients(2007)
- Monoclonal antibody immunoconjugates in the diagnosis and treatment of advanced melanoma.(1992)